As of 2023, an estimated 6.7 million Americans aged 65 and older were living with Alzheimer’s disease, according to the Alzheimer’s Association. With that number projected to more than double to 13.8 ...
The Commercial Spaceflight Federation (CSF) applauds Vice President Harris’ announcement of a United States commitment not to conduct destructive, direct-ascent anti-satellite (ASAT) missile testing.
Roche has received US Food and Drug Administration (FDA) 510(k) clearance for additional cerebrospinal fluid (CSF) assays for Alzheimer’s disease (AD), supporting timely diagnosis and treatment ...
Roche is on a roll: For the second time in less than a year, the company has scored FDA clearance for a pair of assays that can be used together to help spot signs of Alzheimer’s disease. The duo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback